Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4286333
Max Phase: Preclinical
Molecular Formula: C45H74N12O17S
Molecular Weight: 1087.22
Molecule Type: Small molecule
Associated Items:
ID: ALA4286333
Max Phase: Preclinical
Molecular Formula: C45H74N12O17S
Molecular Weight: 1087.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NCCOC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C45H74N12O17S/c1-19(2)30(53-39(67)26-9-8-14-56(26)43(71)33(23(7)59)55-41(69)31(20(3)4)52-37(65)24(46)18-75)40(68)50-25(38(66)54-32(22(6)58)42(70)49-21(5)36(47)64)10-11-28(60)48-13-16-73-17-27-34(62)35(63)44(74-27)57-15-12-29(61)51-45(57)72/h12,15,19-27,30-35,44,58-59,62-63,75H,8-11,13-14,16-18,46H2,1-7H3,(H2,47,64)(H,48,60)(H,49,70)(H,50,68)(H,52,65)(H,53,67)(H,54,66)(H,55,69)(H,51,61,72)/t21-,22+,23+,24-,25-,26-,27+,30-,31-,32-,33-,34+,35+,44+/m0/s1
Standard InChI Key: CLVGYSMLYKOMKL-NENQSVHXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1087.22 | Molecular Weight (Monoisotopic): 1086.5016 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.. (2018) Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids., 9 (5): [PMID:30108977] [10.1039/C8MD00115D] |
Source(1):